Insmed Inc (NASDAQ: INSM) stock enjoyed a major increase of 118.5% on 5/28/24. The shares closed at $48.06. Moreover, this advance was accompanied by exceptionally high trading volume at 1343% of normal. The stock has performed in line with the market over the last nine months and has risen 94.0% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, INSM is expected to continue to be Value Creation neutral.
Insmed is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment